EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Measles Virus-Based Vaccine Expressing Membrane-Anchored Spike of SARS-CoV-2 Inducing Efficacious Systemic and Mucosal Humoral Immunity in Hamsters

Zhi-Hui Yang, Yan-Li Song, Jie Pei, Song-Zhuang Li, Rui-Lun Liu, Yu Xiong, Jie Wu, Yuan-Lang Liu, Hui-Fen Fan, Jia-Hui Wu, Ze-Jun Wang iD, Jing Guo und 4 weitere

Viruses · 2024

DOI: 10.3390/v16040559 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viruses, 2024. Verfasst von Zhi-Hui Yang und 15 weiteren Autor:innen. Beteiligte Einrichtung: Wuhan Institute of Biological Products Co. Ltd., Wuhan 430207, China. Hauptthemen laut MEDLINE: Spike Glycoprotein, Coronavirus, SARS-CoV-2, Antibodies, Viral, Immunity, Mucosal. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The National Key Research and Development Program of China, National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

As SARS-CoV-2 continues to evolve and COVID-19 cases rapidly increase among children and adults, there is an urgent need for a safe and effective vaccine that can elicit systemic and mucosal humoral immunity to limit the emergence of new variants. Using the Chinese Hu191 measles virus (MeV-hu191) vaccine strain as a backbone, we developed MeV chimeras stably expressing the prefusion forms of either membrane-anchored, full-length spike (rMeV-preFS), or its soluble secreted spike trimers with the help of the SP-D trimerization tag (rMeV-S+SPD) of SARS-CoV-2 Omicron BA.2. The two vaccine candidates were administrated in golden Syrian hamsters through the intranasal or subcutaneous routes to determine the optimal immunization route for challenge. The intranasal delivery of rMeV-S+SPD induced a more robust mucosal IgA antibody response than the subcutaneous route. The mucosal IgA antibody induced by rMeV-preFS through the intranasal routine was slightly higher than the subcutaneous route, but there was no significant difference. The rMeV-preFS vaccine stimulated higher mucosal IgA than the rMeV-S+SPD vaccine through intranasal or subcutaneous administration. In hamsters, intranasal administration of the rMeV-preFS vaccine elicited high levels of NAbs, protecting against the SARS-CoV-2 Omicron BA.2 variant challenge by reducing virus loads and diminishing pathological changes in vaccinated animals. Encouragingly, sera collected from the rMeV-preFS group consistently showed robust and significantly high neutralizing titers against the latest variant XBB.1.16. These data suggest that rMeV-preFS is a highly promising COVID-19 candidate vaccine that has great potential to be developed into bivalent vaccines (MeV/SARS-CoV-2).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Spike Glycoprotein, CoronavirusSARS-CoV-2Antibodies, ViralImmunity, MucosalAntibodies, NeutralizingImmunity, HumoralCOVID-19COVID-19 VaccinesMeasles virusImmunoglobulin AAnimalsCricetinaeHumansAdministration, IntranasalMesocricetusFemale

Stichwörter der Autor:innen

Omicron BA.2SARS-CoV-2SP-Dmeasles virusmucosal immunityspike proteintrimerization tag

Substanzen

Spike Glycoprotein, CoronavirusAntibodies, ViralAntibodies, NeutralizingCOVID-19 Vaccinesspike protein, SARS-CoV-2Immunoglobulin A

Autor:innen und Institutionen

  • Wuhan Institute of Biological Products Co. Ltd., Wuhan 430207, China.

ORCID-Profile: Ze-Jun Wang, Shuo Shen

Förderung

  • The National Key Research and Development Program of China
  • National Key Research and Development Program of China

Zitieren

APA

Yang, Z. H., Song, Y. L., Pei, J., Li, S. Z., Liu, R. L., Xiong, Y., Wu, J., Liu, Y. L., Fan, H. F., Wu, J. H., Wang, Z. J., Guo, J., Meng, S. L., Chen, X. Q., Lu, J., & Shen, S. (2024). Measles Virus-Based Vaccine Expressing Membrane-Anchored Spike of SARS-CoV-2 Inducing Efficacious Systemic and Mucosal Humoral Immunity in Hamsters. Viruses. https://doi.org/10.3390/v16040559

Vancouver

Yang ZH, Song YL, Pei J, Li SZ, Liu RL, Xiong Y, et al. Measles Virus-Based Vaccine Expressing Membrane-Anchored Spike of SARS-CoV-2 Inducing Efficacious Systemic and Mucosal Humoral Immunity in Hamsters. Viruses. 2024. doi:10.3390/v16040559

BibTeX
@article{Yang2024,
  author = {Yang, Zhi-Hui and Song, Yan-Li and Pei, Jie and Li, Song-Zhuang and Liu, Rui-Lun and Xiong, Yu and Wu, Jie and Liu, Yuan-Lang and Fan, Hui-Fen and Wu, Jia-Hui and Wang, Ze-Jun and Guo, Jing and Meng, Sheng-Li and Chen, Xiao-Qi and Lu, Jia and Shen, Shuo},
  title = {Measles Virus-Based Vaccine Expressing Membrane-Anchored Spike of SARS-CoV-2 Inducing Efficacious Systemic and Mucosal Humoral Immunity in Hamsters},
  journal = {Viruses},
  year = {2024},
  doi = {10.3390/v16040559}
}
Kostenlos starten →